Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xenon Pharmaceuticals Inc (NQ: XENE ) 39.25 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 39.25 Bid (Size) 15.70 (2) Ask (Size) 62.79 (1) Prev. Close 39.25 Today's Range 39.25 - 39.25 52wk Range 27.98 - 50.99 Shares Outstanding 63,562,303 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting May 28, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Performance YTD -12.60% -12.60% 1 Month +2.64% +2.64% 3 Month -8.78% -8.78% 6 Month -16.76% -16.76% 1 Year +1.71% +1.71% More News Read More XENE Stock Earnings: Xenon Pharmaceuticals Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Earnings Scheduled For February 29, 2024 February 29, 2024 Via Benzinga Earnings Outlook For Xenon Pharmaceuticals February 28, 2024 Via Benzinga 4 Analysts Have This to Say About Xenon Pharmaceuticals December 08, 2023 Via Benzinga Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 May 08, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference May 07, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update May 02, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting April 16, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference April 10, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference April 04, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days March 12, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024 March 05, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update February 29, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update February 22, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire 3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition February 21, 2024 Via InvestorPlace This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space February 16, 2024 Via Benzinga Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024 January 08, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals December 29, 2023 Via MarketBeat Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares December 04, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023) December 02, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Why Xenon Pharmaceuticals Stock (XENE) Is Seeing Blue Skies Today November 30, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
